| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3188838 | Annales de Dermatologie et de Vénéréologie | 2011 | 19 Pages |
Abstract
In the absence of any therapeutic trials, it is difficult to select optimal treatment; however, the benefit/risk ratio of systemic corticosteroid treatment is unfavourable.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
C. Le Roux-Villet, C. Prost-Squarcioni,